Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for long-term reduction of COPD exacerbations
2012-002199-15Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of doxycycline in chronic obstructive pulmonary disease (COPD), sponsored by Imperial College London. Started Aug 2013; status: completed.
02
Drugs
doxycycline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2012-002199-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002199-15.